{"created":"2023-05-15T16:39:11.024492+00:00","id":13052,"links":{},"metadata":{"_buckets":{"deposit":"dbd841f1-633b-4a88-ad2d-195b326962e2"},"_deposit":{"created_by":2,"id":"13052","owners":[2],"pid":{"revision_id":0,"type":"depid","value":"13052"},"status":"published"},"_oai":{"id":"oai:nagasaki-u.repo.nii.ac.jp:00013052","sets":["8:9"]},"author_link":["47524","47523","47521","47520","47519","47522"],"item_2_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2011-03","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"78","bibliographicPageStart":"72","bibliographicVolumeNumber":"16","bibliographic_titles":[{"bibliographic_title":"Journal of Cardiovascular Pharmacology and Therapeutics"}]}]},"item_2_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"It is known that selective cyclooxygenase 2(COX-2) inhibitors increase mortality in patients with previous myocardial infarction, and it has been suggested that COX-2 plays an important role in cardioprotection against ischemia. The current study was carried out to determine whether COX-2 is involved in the mechanisms of sevoflurane- and olprinone-induced early-phase preconditioning (E-PreC) and postconditioning (PostC) in rat hearts.","subitem_description_type":"Abstract"}]},"item_2_description_63":{"attribute_name":"引用","attribute_value_mlt":[{"subitem_description":"Journal of Cardiovascular Pharmacology and Therapeutics, 16(1), pp.72-78; 2011","subitem_description_type":"Other"}]},"item_2_publisher_33":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"SAGE Publications"}]},"item_2_relation_11":{"attribute_name":"PubMed番号","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"20938040","subitem_relation_type_select":"PMID"}}]},"item_2_relation_12":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1177/1074248410380208","subitem_relation_type_select":"DOI"}}]},"item_2_rights_13":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"The final, definitive version of this paper has been published in Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 16/Issue 1, March 2011 by SAGE Publications Ltd, All rights reserved. © The Author(s) 2011."}]},"item_2_source_id_10":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AA11016835","subitem_source_identifier_type":"NCID"}]},"item_2_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"10742484","subitem_source_identifier_type":"ISSN"}]},"item_2_source_id_8":{"attribute_name":"EISSN","attribute_value_mlt":[{"subitem_source_identifier":"19404034","subitem_source_identifier_type":"ISSN"}]},"item_2_version_type_16":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Tosaka, Shinya"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Tosaka, Reiko"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Matsumoto, Shuhei"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Maekawa, Takuji"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Cho, Sungsam"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Sumikawa, Koji"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-12-22"}],"displaytype":"detail","filename":"JCPT16_72.pdf","filesize":[{"value":"264.5 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"JCPT16_72.pdf","url":"https://nagasaki-u.repo.nii.ac.jp/record/13052/files/JCPT16_72.pdf"},"version_id":"856abbd4-a7dd-4035-893b-6ccc10e9ac58"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"cyclooxygenase","subitem_subject_scheme":"Other"},{"subitem_subject":"myocardial ischemia","subitem_subject_scheme":"Other"},{"subitem_subject":"olprinone","subitem_subject_scheme":"Other"},{"subitem_subject":"sevoflurane","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Roles of cyclooxygenase 2 in sevoflurane- and olprinone-induced early phase of preconditioning and postconditioning against myocardial infarction in rat hearts.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Roles of cyclooxygenase 2 in sevoflurane- and olprinone-induced early phase of preconditioning and postconditioning against myocardial infarction in rat hearts."}]},"item_type_id":"2","owner":"2","path":["9"],"pubdate":{"attribute_name":"公開日","attribute_value":"2012-04-01"},"publish_date":"2012-04-01","publish_status":"0","recid":"13052","relation_version_is_last":true,"title":["Roles of cyclooxygenase 2 in sevoflurane- and olprinone-induced early phase of preconditioning and postconditioning against myocardial infarction in rat hearts."],"weko_creator_id":"2","weko_shared_id":-1},"updated":"2023-05-16T00:44:51.215890+00:00"}